CA2263846A1 - Novel pyranoside derivatives - Google Patents

Novel pyranoside derivatives

Info

Publication number
CA2263846A1
CA2263846A1 CA002263846A CA2263846A CA2263846A1 CA 2263846 A1 CA2263846 A1 CA 2263846A1 CA 002263846 A CA002263846 A CA 002263846A CA 2263846 A CA2263846 A CA 2263846A CA 2263846 A1 CA2263846 A1 CA 2263846A1
Authority
CA
Canada
Prior art keywords
derivatives
novel
pyranoside derivatives
novel pyranoside
pyranoside
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002263846A
Other languages
French (fr)
Other versions
CA2263846C (en
Inventor
Ralf Anderskewitz
Kurt Schromm
Ernst-Otto Renth
Franz Birke
Hans Michael Jennewein
Christopher John Montague Meade
Andreas Ding
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Original Assignee
Ralf Anderskewitz
Kurt Schromm
Ernst-Otto Renth
Franz Birke
Hans Michael Jennewein
Christopher John Montague Meade
Andreas Ding
Boehringer Ingelheim International Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ralf Anderskewitz, Kurt Schromm, Ernst-Otto Renth, Franz Birke, Hans Michael Jennewein, Christopher John Montague Meade, Andreas Ding, Boehringer Ingelheim International Gmbh filed Critical Ralf Anderskewitz
Publication of CA2263846A1 publication Critical patent/CA2263846A1/en
Application granted granted Critical
Publication of CA2263846C publication Critical patent/CA2263846C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Abstract

The present invention relates to new pyranoside derivatives of general formula I, processes for preparing them and their use in pharmaceutical compositions.
CA002263846A 1996-09-12 1997-09-10 Novel pyranoside derivatives Expired - Fee Related CA2263846C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19637123.6 1996-09-12
DE19637123A DE19637123A1 (en) 1996-09-12 1996-09-12 New pyranoside derivatives
PCT/EP1997/004948 WO1998011119A1 (en) 1996-09-12 1997-09-10 Novel pyranoside derivatives

Publications (2)

Publication Number Publication Date
CA2263846A1 true CA2263846A1 (en) 1998-03-19
CA2263846C CA2263846C (en) 2006-11-14

Family

ID=7805404

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002263846A Expired - Fee Related CA2263846C (en) 1996-09-12 1997-09-10 Novel pyranoside derivatives

Country Status (16)

Country Link
EP (1) EP0931087B1 (en)
JP (1) JP4215278B2 (en)
AR (1) AR009769A1 (en)
AT (1) ATE215551T1 (en)
AU (1) AU4622597A (en)
CA (1) CA2263846C (en)
DE (2) DE19637123A1 (en)
DK (1) DK0931087T3 (en)
ES (1) ES2174297T3 (en)
HR (1) HRP970487A2 (en)
ID (1) ID18262A (en)
PE (1) PE107398A1 (en)
PT (1) PT931087E (en)
WO (1) WO1998011119A1 (en)
YU (1) YU37597A (en)
ZA (1) ZA978086B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL141654A0 (en) * 1998-09-04 2002-03-10 Byk Gulden Lomberg Chem Fab Pyranose derivatives and pharmaceutical compositions containing the same
US6528491B2 (en) 2000-10-24 2003-03-04 Boehringer Ingelheim Pharma Kg Pyranoside derivatives
DE10052658A1 (en) * 2000-10-24 2002-05-02 Boehringer Ingelheim Pharma New pyranoside derivatives
EP1353661A2 (en) * 2001-01-16 2003-10-22 Boehringer Ingelheim Pharma GmbH & Co.KG Use of an ltb4 antagonist for the treatment and/or prevention of diseases caused by increased expression of mucin genes
JP2005502630A (en) * 2001-07-14 2005-01-27 ベーリンガー インゲルハイム ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト Pharmaceutical preparation containing LTB4 antagonist
WO2017095723A1 (en) 2015-11-30 2017-06-08 Merck Sharp & Dohme Corp. Aryl acylsulfonamides as blt1 antagonists
US10336733B2 (en) 2015-11-30 2019-07-02 Merk Sharp & Dohme Corp. Aryl acylsulfonamides as BLT1 antagonists
WO2017095724A1 (en) 2015-11-30 2017-06-08 Merck Sharp & Dohme Corp. Aryl sulfonamides as blt1 antagonists
WO2017095725A1 (en) 2015-11-30 2017-06-08 Merck Sharp & Dohme Corp. Aryl sulfonamides as blt1 antagonists
JP7373191B2 (en) * 2017-05-12 2023-11-02 国立研究開発法人理化学研究所 Class A GPCR-binding compound variants

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5246965A (en) * 1991-06-11 1993-09-21 Ciba-Geigy Arylethers, their manufacture and methods of treatment
PL173781B1 (en) * 1992-02-05 1998-04-30 Boehringer Ingelheim Kg Method of obtaining novel derivatives of amidine
DE19546452A1 (en) * 1995-12-13 1997-06-19 Boehringer Ingelheim Kg New phenylamidine derivatives, process for their preparation and their use as medicaments

Also Published As

Publication number Publication date
JP4215278B2 (en) 2009-01-28
ES2174297T3 (en) 2002-11-01
EP0931087A1 (en) 1999-07-28
DK0931087T3 (en) 2002-07-01
CA2263846C (en) 2006-11-14
ZA978086B (en) 1998-03-12
YU37597A (en) 1999-11-22
ID18262A (en) 1998-03-19
HRP970487A2 (en) 1998-08-31
JP2001500146A (en) 2001-01-09
DE59706897D1 (en) 2002-05-08
PE107398A1 (en) 1999-02-03
ATE215551T1 (en) 2002-04-15
WO1998011119A1 (en) 1998-03-19
PT931087E (en) 2002-09-30
AU4622597A (en) 1998-04-02
AR009769A1 (en) 2000-05-03
DE19637123A1 (en) 1998-03-19
EP0931087B1 (en) 2002-04-03

Similar Documents

Publication Publication Date Title
CA2278201A1 (en) Novel modifications to 2-amino-4-(4-fluorobenzylamino)-1-ethoxycarbonyl-aminobenzene, and processes for their preparation
HUP0203542A3 (en) 3(5)-amino-pyrazole derivatives, process for their preparation, their use and pharmaceutical compositions containing the same
AU3080895A (en) Novel piperazides derived from arylpiperazine, processes for their preparation, their use as medicaments and pharmaceutical compositions comprising them
CA2274464A1 (en) Ketobenzamides as calpain inhibitors
CA2400268A1 (en) Pyrrolopyrimidinone derivatives, process of preparation and use
CA2243504A1 (en) New 19-nor-pregnene derivatives
CA2150251A1 (en) Lyospheres comprising gonadotropin
CA2223094A1 (en) Phenylpyridazinones
CA2201477A1 (en) New pyrimidone derivatives with antifungal activity
CA2163837A1 (en) Crystalline Paclitaxel Hydrates
CA2338600A1 (en) Novel thiazolopyrimidine compounds
IL94433A0 (en) Aminophenol derivatives,their preparation and pharmaceutical compositions containing them
CA2152771A1 (en) 7-o-ethers of taxane derivatives
HUP9901616A3 (en) Novel benzofuranone derivatives, process for their production and pharmaceutical compositions of the same
MY120683A (en) New phenylamidine derivatives, processes for their preparation and their use as pharmaceuticals.
AU8315287A (en) New alkanesulfonanilide and alkylaminosulfonanilide derivatives, processes for their preparation and pharmaceutical compositions comprising the same
CA2263846A1 (en) Novel pyranoside derivatives
MY120550A (en) Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols, processes for preparing them and their use as pharmaceutical compositions.
CA2127472A1 (en) New adenosine derivatives, preparation methods and pharmaceutical compositions containing them
CA2337667A1 (en) Dextran-leptin conjugates, pharmaceutical compositions and related methods
CA2188796A1 (en) Heterocyclylbenzonitriles
CA2269128A1 (en) Piperazino derivatives as neurokinin antagonists
GB2235198B (en) Novel aminopropanol derivatives,process for their preparation and pharmaceutical compositions comprising the same
EP0386920A3 (en) 2-hydroxy-3-thienyloxypropylamino derivatives
CA2302412A1 (en) Aminoalkylphenol derivatives and related compounds

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed